4//SEC Filing
Faleck Herbert J 4
Accession 0001127602-18-021568
CIK 0001472091other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:17 PM ET
Size
5.1 KB
Accession
0001127602-18-021568
Insider Transaction Report
Form 4
Faleck Herbert J
Chief Medical Officer
Transactions
- Award
Stock Option (Right To Purchase)
2018-06-19+119,667→ 119,667 totalExercise: $1.10→ Common Stock (119,667 underlying)
Footnotes (2)
- [F1]These options shall become exercisable upon the achievement of certain performance or time based criteria.
- [F2]These options expire on the third anniversary of the vesting date.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001652994
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:17 PM ET
- Size
- 5.1 KB